Bioactive Compounds and Diabetes Mellitus: Prospects and Future Challenges

Area of Science:

• Endocrinology
• Metabolic Disorders
• Pharmacology

Background:

• Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia and hyperlipidemia, leading to severe complications.
• Current diabetes medications, while effective in managing blood glucose, often present significant adverse effects.
• Existing treatments aim to normalize systemic circulation glucose levels but may not address underlying metabolic dysregulation comprehensively.

Purpose of the Study:

• To explore the potential of bioactive compounds in managing diabetes mellitus.
• To review the antidiabetic activity of plant-derived bioactive compounds.
• To discuss the prospects of using natural compounds as an alternative or complementary therapy for diabetes.

Main Methods:

• Literature review of studies on bioactive compounds and their effects on diabetes.
• Analysis of research investigating the mechanisms of action of natural compounds in metabolic pathways.
• Evaluation of comparative efficacy of plant-derived compounds versus oral hypoglycemic agents.

Main Results:

• Bioactive compounds, particularly those isolated from plants, exhibit significant antidiabetic activity.
• These natural compounds demonstrate efficacy in controlling and adjusting metabolic pathways.
• Plant-derived bioactive compounds show potential for greater effectiveness than some current oral hypoglycemic agents.

Conclusions:

• Bioactive compounds offer a promising avenue for diabetes mellitus management due to their natural origin and metabolic regulatory properties.
• While promising, further rigorous clinical studies are essential to validate the efficacy and safety of bioactive compounds for diabetes management.
• Natural bioactive compounds represent a potential therapeutic strategy with fewer side effects compared to some synthetic drugs.